Analysis of PI3K/mTOR Pathway Biomarkers and Their Prognostic Value in Women with Hormone Receptor–Positive, HER2-Negative Early Breast Cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference38 articles.
1. Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer;Katso;Annu Rev Cell Dev Biol,2001
2. Structure of the human mTOR complex I and its implications for rapamycin inhibition;Yip;Mol Cell,2010
3. Targeting mTOR in cancer: renal cell is just a beginning;Azim;Target Oncol,2010
4. The NO-modified HIV protease inhibitor as a valuable drug for hematological malignancies: role of p70S6K;Maksimovic-Ivanic;Leuk Res,2015
5. Saquinavir-NO inhibits S6 kinase activity, impairs secretion of the encephalytogenic cytokines interleukin-17 and interferon-gamma and ameliorates experimental autoimmune encephalomyelitis;Petkovic;J Neuroimmunol,2013
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The prognosis of patients treated with everolimus for advanced ER‐positive, HER2‐negative breast cancer is driven by molecular features;The Journal of Pathology: Clinical Research;2024-04-02
2. Optimal targeting of PI3K-AKT and mTOR in advanced oestrogen receptor-positive breast cancer;The Lancet Oncology;2024-04
3. LncRNA MALAT1 Expression Regulates Breast Cancer Progression via PI3K/AKT/mTOR Pathway Modulation;Biochemical Genetics;2023-12-18
4. PIK3CA mutation correlates with mTOR pathway expression but not clinical and pathological features in Fibro-adipose vascular anomaly (FAVA);Diagnostic Pathology;2022-01-30
5. Molecular Progression of Breast Cancer and Personalized Medicine in Terms of Clinical Trials;Breast Cancer: From Bench to Personalized Medicine;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3